Delivery Order SPE2DB22D3501-SPE2DB24FTN77
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB24FT1JF) from the Defense Logistics Agency (DLA) valued at $11,427.67. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period ending on January 16, 2024. The contract is a Firm Fixed Price, and there is no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $5,135.28, is for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range...
- This federal contract award, valued at $7,539.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, with a ceiling value of $29,686.30 and an ultimate completion date of July 13, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating...
- This federal contract award, valued at $5,995.75, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of December 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $7,793.11, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract has a period of performance through February 28, 2024 and is a firm-fixed-price delivery order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has an estimated ceiling value of $19,543.59 and is a delivery order contract for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of November 7, 2023 and is a firm fixed-price arrangement. This award is not designated with any set-aside requirements, indicating...
- This federal contract award, valued at $9,433.76, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of December 20, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award was made without any set-aside designation, indicating open competition....
- This federal contract award, valued at $30,336.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTN77Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract, valued at $4,902.66, is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support federal government healthcare needs. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and a critical supplier of medical products to various federal agencies, particularly the Department of Defense and Department of Veterans Affairs. The company's DLA Troop Support Medical IDC, valued at up to $999,999,999.00, serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 11/16/23 |